$PPHM News Peregrine plunges on test data 3:17 p.m. June

New Post Public Reply Private Reply Replies (0) Message Board

Jan 7, 2014 at 12:55 PM

$PPHM News

Peregrine plunges on test data 3:17 p.m. June 27, 2013 - Russ Britt
Small-cap makes a splash with FDA nod for cancer drug 2:16 p.m. May 20, 2013 - Russ Britt
Peregrine drug shows promise in pancreatic cancer 12:17 p.m. Feb. 13, 2013 - MarketWatch.com
In focus: Bullish, but overbought 7:06 p.m. Jan. 9, 2013 - Lawrence G. McMillan
Hedge funds are bullish on these stocks 10:57 a.m. Dec. 5, 2012 - Insider Monkey
Peregrine, FDA agree on brain-cancer drug study 10:56 a.m. Dec. 5, 2012 - MarketWatch.com
Drug trial contractors improve efficiency 9:24 a.m. Nov. 16, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 5:42 p.m. Sept. 25, 2012 - Greg Morcroft
Tuesday’s biggest gaining and declining stocks 4:09 p.m. Sept. 25, 2012 - Greg Morcroft
Peregrine Pharma down 86% after test data review 7:27 a.m. Sept. 24, 2012 - Steve Gelsi
Peregrine Pharma down 86% in premarket 7:18 a.m. Sept. 24, 2012 - Steve Gelsi
Peregrine reviewing Bavituximab results 6:42 a.m. Sept. 24, 2012 - Greg Morcroft
Some previous Bavituximab data not valid

eregrine 6:42 a.m. Sept. 24, 2012 - Greg Morcroft
Monday’s biggest gaining and declining stocks 1:42 p.m. Sept. 10, 2012 - MarketWatch
Regions Financial, Williams-Sonoma hit 52-week highs; Intel, Cisco active 10:11 a.m. Sept. 10, 2012 - blogs.marketwatch.com
Stocks to watch Monday: AIG, Michael Kors, Sears 5:41 a.m. Sept. 10, 2012 - MarketWatch
Peregrine rallies on bavituximab lung-cancer data 12:29 p.m. Sept. 7, 2012 - MarketWatch.com
Monday’s biggest gaining & declining stocks 1:53 p.m. Aug. 27, 2012 - MarketWatch
Peregrine Pharma slides 12% after negative report 1:21 p.m. Aug. 27, 2012 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 3:23 p.m. May 21, 2012 - MarketWatch

Peregrine Pharmaceuticals (PPHM) Soars: Stock Adds 14.5% in Session - Tale of the Tape 8:57 a.m. Today - Zacks.com
Why Peregrine Pharmaceuticals (PPHM) is Surging 10:41 a.m. Jan. 6, 2014 - TheStreet.com
Peregrine Pharma Initiates Bavituximab Study - Analyst Blog 5:20 p.m. Dec. 31, 2013 - Zacks.com
Peregrine Pharmaceuticals Initiates Sunrise Pivotal Phase III Clinical Trial of Bavituximab in Second-Line Non-Small Cell Lung Cancer 6:37 a.m. Dec. 30, 2013 - benzinga.com
Consider Buy Rated Stocks Under Five Bucks as Stocking Stuffers 10:28 a.m. Dec. 23, 2013 - TheStreet.com
Peregrine Reports In-Line Loss - Analyst Blog 2:10 p.m. Dec. 11, 2013 - Zacks.com
Peregrine Pharmaceuticals Management Discusses Q2 2014 Results - Earnings Call Transcript 7:20 p.m. Dec. 10, 2013 - Seeking Alpha
10-Q: PEREGRINE PHARMACEUTICALS INC 5:34 p.m. Dec. 10, 2013 - Edgar Online - (EDG = 10Q, 10K)
Peregrine Pharmaceuticals (PPHM) Jumps: Stock Rises 6.2% - Tale of the Tape 9:39 a.m. Nov. 22, 2013 - Zacks.com
The Race For A Cure For Cancer 1:44 p.m. Nov. 20, 2013 - Seeking Alpha
Peregrine's Bavituximab in Combination With Anti-CTLA-4 Antibodies Yields Enhanced Anti-Tumor Activity in Pre-Clinical Model of Melanoma 8:10 a.m. Nov. 8, 2013 - benzinga.com
Peregrine Pharmaceuticals is now in Oversold Territory - Tale of the Tape 7:06 a.m. Nov. 8, 2013 - Zacks.com
2013 Biotech Watchlist Update: Companies Climb And Crumble On Catalysts 10:48 a.m. Nov. 1, 2013 - Seeking Alpha
Peregrine Pharmaceuticals' CEO Hosts Annual Meeting of Stockholders (Transcript) 8:00 p.m. Oct. 17, 2013 - Seeking Alpha
Peregrine Pharmaceuticals, Inc. - Shareholder/Analyst Call 8:00 p.m. Oct. 17, 2013 - Seeking Alpha
Biotech: Let's Make A Billion-Dollar Deal, Part 2 2:00 p.m. Oct. 1, 2013 - Seeking Alpha
Peregrine Pharmaceuticals Earnings: Here’s Why Investors are Not Excited Now 8:58 a.m. Sept. 10, 2013 - Wall St. Cheat Sheet
Peregrine Reports In-Line Loss - Analyst Blog 8:30 a.m. Sept. 10, 2013 - Zacks.com
Peregrine Pharmaceuticals Management Discusses Q1 2014 Results - Earnings Call Transcript 6:10 p.m. Sept. 9, 2013 - Seeking Alpha
10-Q: PEREGRINE PHARMACEUTICALS INC 3:24 p.m. Sept. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)

Peregrine Pharmaceuticals Receives FDA Fast Track Designation for Its Immunotherapy Bavituximab as a Potential Treatment of Second-Line Non-Small Cell Lung Cancer 7:30 a.m. Jan. 6, 2014 - Marketwire
Peregrine Pharmaceuticals Initiates Sunrise Pivotal Phase III Clinical Trial of Bavituximab in Second-Line Non-Small Cell Lung Cancer 7:31 a.m. Dec. 30, 2013 - Marketwire
Peregrine Pharmaceuticals Reports Second Quarter Fiscal Year 2014 Financial Results and Recent Developments 4:00 p.m. Dec. 10, 2013 - Marketwire
Peregrine Pharmaceuticals Announces Upcoming Events 4:00 p.m. Nov. 26, 2013 - Marketwire
Today's Research: Celgene Corp., Forest Laboratories Inc., Edwards Lifesciences Corp., and Peregrine Pharma Inc. 1:30 p.m. Nov. 22, 2013 - PR Newswire
OXBT, HZNP, PPHM and NWBO added to NASDAQ Healthcare Stock Watch List at GSR 10:35 a.m. Nov. 11, 2013 - ACCESSWIRE
Data Presentation at Society for Immunotherapy of Cancer Annual Meeting Supports Potential of Peregrine Pharmaceuticals' Novel Immunotherapy Bavituximab in Combination With Anti-CTLA-4 Antibodies 9:01 a.m. Nov. 8, 2013 - Marketwire
Peregrine Pharmaceuticals to Present at Credit Suisse 2013 Healthcare Conference 4:00 p.m. Nov. 5, 2013 - Marketwire
Pre-Market Review: Celgene Corp., Forest Laboratories Inc., Peregrine Pharma Inc., and Edwards Lifesciences Corp. 3:03 p.m. Oct. 31, 2013 - PR Newswire
Symposium at IALSC World Conference on Lung Cancer to Highlight Novel Immune Checkpoints Including Peregrine Pharmaceuticals' Bavituximab PS Target 7:31 a.m. Oct. 15, 2013 - Marketwire
Pre-Market Review: Celgene Corp., Forest Laboratories Inc., Peregrine Pharma Inc., and Edwards Lifesciences Corp. 10:25 a.m. Oct. 9, 2013 - PR Newswire
Record Use of At-the-Market (ATM) Offerings by U.S. Life Sciences Companies in First Half of 2013, Reports Brinson Patrick 7:00 a.m. Sept. 17, 2013 - PR Newswire
Peregrine Pharmaceuticals Reports First Quarter Fiscal Year 2014 Financial Results and Recent Developments 3:00 p.m. Sept. 9, 2013 - Marketwire
Data Supporting Bavituximab's Immunotherapy Mechanism of Action Published in the Peer-Reviewed AACR Journal Cancer Immunology Research 7:31 a.m. Sept. 9, 2013 - Marketwire
Early Briefing and Review: Celgene Corp., Edwards Lifesciences Corp., Forest Laboratories Inc., and Peregrine Pharma Inc. 4:11 p.m. Sept. 6, 2013 - PR Newswire
Peregrine to Report First Quarter Fiscal Year 2014 Financial Results After Market Close on September 9, 2013 3:06 p.m. Sept. 3, 2013 - Marketwire
Bavituximab's Mechanism of Action Highlighted at Immunomodulatory Therapeutic Antibodies for Cancer Conference 2:01 p.m. Aug. 14, 2013 - Marketwire
Peregrine Pharmaceuticals to Present at Upcoming Conferences 3:00 p.m. Aug. 6, 2013 - Marketwire
Morning Research: Celgene, Edwards Lifesciences, Forest Laboratories, and Peregrine Pharma 8:12 a.m. July 31, 2013 - PR Newswire
Peregrine Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2013 Financial Results and Recent Developments 3:06 p.m. July 11, 2013 - Marketwire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Global Movement Urges Dr. Hak Ja Han's Release

Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...

Baidu's Stock Connect Inclusion: What It Means for Investors

An Intriguing Move For Baidu's Class A Shares Well, here we go again, folks. Another move on the chessboard for Baidu. They've just walked their Class A ordinary shares onto the Shenzhen-Hong Kong and Shanghai-Hong Kong Stock Connects. As of today, September 7, 2026, mainland investors can now get their mitts on these shares more easily. It might not be a...

WEPSEA 2026 Propels Southeast Asia's Packaging Leap

Revolution in Packaging: Southeast Asia Steps Up Get ready for a wake-up call in the world of packaging, folks; the Southeast Asian market is taking a sharp turn toward sustainability and technological advancement, as highlighted by WEPSEA 2026's recent wrap-up in Shanghai. Far from a mere exhibition, this gathering served as the crucible for change, where old-school...

Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Mermaid Folklore Meets Revolution in New Short Film

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

MERACH Unveils W60 Plus: A Game Changer for Home Fitness

MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...

Hims & Hers Faces Class Action: Investors Beware

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Media Forum Spotlights Asia-Pacific Cooperation

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Softcare Facilitates Standards Delegation Visit to Senegal

Ever seen a whole nation's hygiene industry getting a deep dive from not just one, but three major standards bodies? That's what just went down in Senegal. Softcare opened its doors wide to folks from the Senegalese Association for Standardization (ASN), the International Organization for Standardization (ISO), and the Swedish Institute for Standards (SIS). This was no...

DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...